Intellia Therapeutics, Inc. (LON:0JBU)
London flag London · Delayed Price · Currency is GBP · Price in USD
7.16
+0.22 (3.17%)
At close: Apr 17, 2025

Intellia Therapeutics Market Cap

Intellia Therapeutics has a market cap or net worth of 630.50 million as of April 24, 2025. Its market cap has decreased by -67.20% in one year.

Market Cap
630.50M
Enterprise Value
139.98M
Revenue
46.23M
Ranking
n/a
PE Ratio
n/a
Stock Price
7.16

Market Cap Chart

Since May 6, 2016, Intellia Therapeutics's market cap has increased from 537.16M to 630.50M, an increase of 17.38%. That is a compound annual growth rate of 1.80%.

History

DateMarket Cap% Change
Apr 23, 2025630.50M-33.53%
Dec 31, 2024948.58M-55.75%
Dec 29, 20232.14B-13.15%
Dec 30, 20222.47B-62.02%
Dec 31, 20216.50B152.49%
Dec 31, 20202.57B375.35%
Dec 31, 2019 Pro Pro
Dec 31, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
AstraZeneca 160.68B
GSK plc 56.48B
Haleon 34.34B
Smith & Nephew 8.78B
ConvaTec Group 5.22B
Hikma Pharmaceuticals 4.20B
HUTCHMED (China) 1.98B
Oxford Nanopore Technologies 1.15B
Market Cap Rankings